HUMAN PAPILLOMAVIRUS
Clinical trials for HUMAN PAPILLOMAVIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fewer shots for HPV protection? study tests 2-Dose vaccine schedule
⭐️ VACCINE ⭐️ Recruiting nowThis study aims to see if two doses of the approved 9-valent HPV vaccine provide similar protection against the virus as the standard three-dose schedule for women aged 27-45. Researchers will enroll 618 women who have never received the HPV vaccine and randomly assign them to re…
Matched conditions: HUMAN PAPILLOMAVIRUS
Phase: PHASE4 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 25, 2026 14:08 UTC
-
Could a simpler test make HPV screening more accessible?
Diagnosis Recruiting nowThis study is testing a new, simpler HPV test designed to be used right in a clinic. Researchers want to see if this new test gives the same results as the standard, more complex HPV tests. The goal is to help develop easier and more accessible screening tools for human papilloma…
Matched conditions: HUMAN PAPILLOMAVIRUS
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Mar 23, 2026 15:19 UTC
-
Scientists hunt for clues to stop unstoppable HPV
Knowledge-focused Recruiting nowThis study aims to discover why some people develop severe, recurring, and treatment-resistant warts and lesions from HPV, while others do not. Researchers will follow 850 participants, including people with these severe infections and their healthy family members, for up to 10 y…
Matched conditions: HUMAN PAPILLOMAVIRUS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC